Indo Us Bio Tech Ltd vs Sampre Nutritions Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Sep 27, 2026

Key Highlights

The Latest Trading Price of Indo US Bio-Tech Ltd is ₹ 80.5 as of 25 Sep 15:30 . The P/E Ratio of Indo US Bio-Tech Ltd changed from 4 on March 2021 to 12.2 on March 2022 . This represents a CAGR of 74.64% over 2 yearsThe P/E Ratio of Sampre Nutritions Ltd changed from 178.9 on March 2023 to 0 on March 2022 . This represents a CAGR of -100.00% over 6 years The Market Cap of Indo US Bio-Tech Ltd changed from ₹ 19.75 crore on March 2021 to ₹ 49.15 crore on March 2022 . This represents a CAGR of 57.75% over 2 yearsThe Market Cap of Sampre Nutritions Ltd changed from ₹ 62.7 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 6 years The revenue of Indo US Bio-Tech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sampre Nutritions Ltd for the Jun '26 is ₹ 14.92 crore as compare to the Mar '26 revenue of ₹ 15.77 crore. This represent the decline of -5.39% The ebitda of Indo US Bio-Tech Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sampre Nutritions Ltd for the Jun '26 is ₹ 1.57 crore as compare to the Mar '26 ebitda of ₹ 1.1 crore. This represent the growth of 42.73% The net profit of Indo US Bio-Tech Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Sampre Nutritions Ltd changed from ₹ 0.1 crore to ₹ 0.7 crore over 9 quarters. This represents a CAGR of 137.46% The Dividend Payout of Indo US Bio-Tech Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Sampre Nutritions Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Indo US Bio-Tech Ltd

Indo Us Bio-Tech Limited was originally incorporated as 'Pollucid Bio-Tech Private Limited' at Junagadh on February 4, 2004.
Subsequently, the name was change to 'Pellucid Bio-Tech Private Limited' on January 5, 2005.
Later on, the name of the Company was changed to 'Indo Us Bio-Tech Private Limited' on March 9, 2007.
Consequently, upon conversion into Public Limited Company, the name of the Company was changed to 'Indo Us Bio-Tech Limited' on January 11, 2018. The Company is an ISO 9001-2008 company, involved in crop research & development throw breeding, production of seeds, processing, packing and marketing of high performing hybrid and open pollinated varieties of agricultural crops.
The Company has its seed processing plants located in Gujarat, where the seeds are processed, stored and packed with the help of modern machineries.

About Sampre Nutritions Ltd

Sampre Nutritions Limited., incorporated in 1991 was promoted by The Gurbani Group, having its works at Medchal, in Andhra Pradesh.
The Company is into the activity of manufacturing of Sugar Candies.
The Company has been manufacturing candy products for its major customer, Cadbury India Ltd since August 1996.
In 2000, it entered into agreement to manufacture 'DAIRY MILK ECLAIRS'. During 1999, the Company commissioned two new projects for manufacture of Jelly in cups under the brand name 'GOLLUM' and 'Mr POPS'. The company was also into the production of HERICOF Cough Lozenges for Ranbaxy Laboratories Ltd, whereby it manufactures CHESTO cough drops for export to its customer 'The Maharaja Organisation Ltd' of Sri Lanka. During 2000, the Company got a major break-through during as it has commenced supplying confectionery products from April 2000 to the various depots of the Indian Airlines across the country The Company launched 6 flavors of Hard Boiled Candy under 'Sampre' Brand in first phase during the year 2018.

FAQs for the comparison of Indo US Bio-Tech Ltd and Sampre Nutritions Ltd

Which company has a larger market capitalization, Indo US Bio-Tech Ltd or Sampre Nutritions Ltd?

Market cap of Indo US Bio-Tech Ltd is 161 Cr while Market cap of Sampre Nutritions Ltd is 57 Cr

What are the key factors driving the stock performance of Indo US Bio-Tech Ltd and Sampre Nutritions Ltd?

The stock performance of Indo US Bio-Tech Ltd and Sampre Nutritions Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indo US Bio-Tech Ltd and Sampre Nutritions Ltd?

As of September 27, 2026, the Indo US Bio-Tech Ltd stock price is INR ₹80.5. On the other hand, Sampre Nutritions Ltd stock price is INR ₹6.02.

How do dividend payouts of Indo US Bio-Tech Ltd and Sampre Nutritions Ltd compare?

To compare the dividend payouts of Indo US Bio-Tech Ltd and Sampre Nutritions Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.